Search | PALTmed

JAMDA

January 9, 2018

The Cost-Effectiveness of Using PARO, a Therapeutic Robotic Seal, to Reduce Agitation and Medication Use in Dementia: Findings from a Cluster–Randomized Controlled Trial

To examine the within-trial costs and cost-effectiveness of using PARO, compared with a plush toy and usual care, for reducing agitation and medication use in people with dementia in long-term care.

JAMDA

September 24, 2018

Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission

For persons with dementia, the appropriate duration of cholinesterase inhibitor (ChEI) use remains unclear. We examined patterns of ChEI use during nursing home (NH) transition and the factors associated with discontinuation following admission.

JAMDA

January 6, 2021

Feasible and Appropriate Strategies for Implementing Evidence-Based Practices in Nursing Homes

JAMDA

February 23, 2021

Use of Smart Glass Technology for Resident Education in Long Term Care Facilities During the COVID-19 Pandemic

JAMDA

February 23, 2021

Undernutrition and Overnutrition Can Be Identified and Addressed in Long-Term Care Residents: A Performance Improvement Project

JAMDA

February 23, 2021

Using the Kano Model Survey for Quality of Life Improvement in the Long-Term Care Setting During COVID-19

JAMDA

February 23, 2021

Development of Minimum Data Set-based Individualized Care Pathways for Chronic Obstructive Pulmonary Disease Treatment in Nursing Home Residents

JAMDA

February 23, 2021

Challenges for Geriatricians: A Case Report of Homebound Dual Sensory Impairment Patient With Social Isolation During COVID-19

JAMDA

December 27, 2020

Hope Springs Eternal: Can Project ECHO Transform Nursing Homes?

JAMDA

November 19, 2020

Effects of an Integrated Palliative Care Pathway: More Proactive GPs, Well Timed, and Less Acute Care: A Clustered, Partially Controlled Before-After Study

This study presents the design of an integrated, proactive palliative care pathway covering the full care cycle and evaluates its effects using 3 types of outcomes: (1) physician-reported outcomes, (2) outcomes reported by family, and (3) (utilization of) health care outcomes.